Gwynn Douglas Long

Professor of Medicine

Medicine, Hematologic Malignancies and Cellular Therapy

gwynn.long@duke.edu

Box 3961 Med Ctr, Durham, NC 27710

Cellular Therapy ABMT, Box 3961 DUMC, Durham, NC 27705

More About This Person

At a Glance

Credentials
1. Education
2. Training & Certifications

Academic Experience
1. Current Appointments & Affiliations
2. Previous Appointments & Affiliations

Expertise

Research
1. Selected Grants

Publications
1. Selected Publications

Artistic Works / Events

Teaching

Advising & Mentoring

Recognition

Professional Activities

Embed Profile Data

Embed Profile Data

Selected Grants

BEAT-MS

Clinical TrialCo Investigator · Awarded by Immune Tolerance Network · 2020 - 2028

An Open-label Pilot Multicenter Study to Evaluate the Safety and Efficacy of ADCT-301 in Patients with Relapsed or Refractory CD25-positive Acute Myeloid Leukemia, myelodysplastic syndrome, or myeloproliferative neoplasms

Clinical TrialPrincipal Investigator · Awarded by ADC Therapeutics Sarl · 2020 - 2025

BEAT-MS

Clinical TrialCo Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2021 - 2025

A Phase I Open Label Study of Panobinostat in combination with Lenalidomide, Bortezomib, and Dexamethasone in patients with relapsed and relapsed/refractory Multiple Myeloma

Clinical TrialPrincipal Investigator · Awarded by Dana-Farber/Partners CancerCare, Inc. · 2014 - 2023

A Randomized, Dbl-Blind, Placebo-Controlled, Parallel-Grp, Multictr, Ph 3 Study-Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients

Clinical TrialPrincipal Investigator · Awarded by Chimerix, Inc. · 2013 - 2016